The Direct-to-Consumer Genetic Testing Market, valued at USD 1.71 billion in 2023, is projected to reach USD 7.59 billion by 2032, growing at a CAGR of 17.64% (2024–2032). Market growth is driven by rising consumer demand for personalized healthcare, ancestry tracing, and preventive health insights. Key trends include online kit sales, AI-powered genetic analysis, and telehealth integration, while data privacy concerns and test variability remain key challenges.